Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Review ArticleReview
Open Access

Pyroptosis in cancer: a dual regulator of tumor cell fate and immune activation

Yuewen Zhang, Mengshi Luo, Zhiqi Liao, Qiuyang Xu, Ding Ma, Qinglei Gao, Tao Zhu and Yong Fang
Cancer Biology & Medicine October 2026, 23 (10) 1380-1401; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0826
Yuewen Zhang
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mengshi Luo
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhiqi Liao
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiuyang Xu
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ding Ma
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qinglei Gao
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tao Zhu
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tao Zhu
  • For correspondence: tjogzt{at}gmail.com tongjify{at}tjh.tjmu.edu.cn
Yong Fang
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yong Fang
  • For correspondence: tjogzt{at}gmail.com tongjify{at}tjh.tjmu.edu.cn
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Elmore S.
    Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35: 495–516.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Carneiro BA,
    2. El-Deiry WS.
    Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020; 17: 395–417.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Li M,
    2. Wang D,
    3. He J,
    4. Chen L,
    5. Li H.
    Bcl-XL: a multifunctional anti-apoptotic protein. Pharmacol Res. 2020; 151: 104547.
  4. 4.↵
    1. Janes PW,
    2. Vail ME,
    3. Ernst M,
    4. Scott AM.
    Eph receptors in the immunosuppressive tumor microenvironment. Cancer Res. 2021; 81: 801–5.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Huang K,
    2. Luo W,
    3. Fang J,
    4. Yu C,
    5. Liu G,
    6. Yuan X, et al.
    Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment. BMC Cancer. 2023; 23: 55.
    OpenUrlPubMed
  6. 6.↵
    1. Baldominos P,
    2. Barbera-Mourelle A,
    3. Barreiro O,
    4. Huang Y,
    5. Wight A,
    6. Cho JW, et al.
    Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell. 2022; 185: 1694–708.e19.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Wang Y,
    2. Kanneganti TD.
    From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J. 2021; 19: 4641–57.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Liu J,
    2. Hong M,
    3. Li Y,
    4. Chen D,
    5. Wu Y,
    6. Hu Y.
    Programmed cell death tunes tumor immunity. Front Immunol. 2022; 13: 847345.
  9. 9.↵
    1. Hou J,
    2. Hsu JM,
    3. Hung MC.
    Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity. Mol Cell. 2021; 81: 4579–90.
    OpenUrlPubMed
  10. 10.↵
    1. Qi S,
    2. Wang Q,
    3. Zhang J,
    4. Liu Q,
    5. Li C.
    Pyroptosis and its role in the modulation of cancer progression and antitumor immunity. Int J Mol Sci. 2022; 23: 10494.
  11. 11.↵
    1. Cookson BT,
    2. Brennan MA.
    Pro-inflammatory programmed cell death. Trends Microbiol. 2001; 9: 113–4.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Shi J,
    2. Zhao Y,
    3. Wang Y,
    4. Gao W,
    5. Ding J,
    6. Li P, et al.
    Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014; 514: 187–92.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Shi J,
    2. Zhao Y,
    3. Wang K,
    4. Shi X,
    5. Wang Y,
    6. Huang H, et al.
    Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015; 526: 660–5.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Ding J,
    2. Wang K,
    3. Liu W,
    4. She Y,
    5. Sun Q,
    6. Shi J, et al.
    Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016; 535: 111–6.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Xia S,
    2. Hollingsworth LR 4th.,
    3. Wu H.
    Mechanism and regulation of gasdermin-mediated cell death. Cold Spring Harb Perspect Biol. 2020; 12: a036400.
  16. 16.↵
    1. Tamura M,
    2. Tanaka S,
    3. Fujii T,
    4. Aoki A,
    5. Komiyama H,
    6. Ezawa K, et al.
    Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner. Genomics. 2007; 89: 618–29.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Burdette BE,
    2. Esparza AN,
    3. Zhu H,
    4. Wang S.
    Gasdermin D in pyroptosis. Acta Pharm Sin B. 2021; 11: 2768–82.
    OpenUrlPubMed
  18. 18.↵
    1. Zhao Y,
    2. Shi J,
    3. Shao F.
    Inflammatory caspases: activation and cleavage of Gasdermin-D in vitro and during pyroptosis. Methods Mol Biol. 2018; 1714: 131–48.
    OpenUrlPubMed
  19. 19.↵
    1. Zhou Z,
    2. He H,
    3. Wang K,
    4. Shi X,
    5. Wang Y,
    6. Su Y, et al.
    Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020; 368: eaaz7548.
  20. 20.↵
    1. Zhang Z,
    2. Zhang Y,
    3. Xia S,
    4. Kong Q,
    5. Li S,
    6. Liu X, et al.
    Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020; 579: 415–20.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Hu Y,
    2. Jiang Y,
    3. Li S,
    4. Ma X,
    5. Chen M,
    6. Yang R, et al.
    The Gasdermin D N-terminal fragment acts as a negative feedback system to inhibit inflammasome-mediated activation of Caspase-1/11. Proc Natl Acad Sci U S A. 2022; 119: e2210809119.
  22. 22.↵
    1. Mu M,
    2. Yu Q,
    3. Zhang Q,
    4. Guo J,
    5. Wang X,
    6. Sun X, et al.
    A pan-cancer analysis of molecular characteristics and oncogenic role of gasdermins. Cancer Cell Int. 2022; 22: 80.
    OpenUrlPubMed
  23. 23.↵
    1. Wang WJ,
    2. Chen D,
    3. Jiang MZ,
    4. Xu B,
    5. Li XW,
    6. Chu Y, et al.
    Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins. J Dig Dis. 2018; 19: 74–83.
    OpenUrlPubMed
  24. 24.
    1. Liu J,
    2. Gao L,
    3. Zhu X,
    4. Geng R,
    5. Tao X,
    6. Xu H, et al.
    Gasdermin D is a novel prognostic biomarker and relates to TMZ response in glioblastoma. Cancers (Basel). 2021; 13: 5620.
    OpenUrlPubMed
  25. 25.↵
    1. Wu LS,
    2. Liu Y,
    3. Wang XW,
    4. Xu B,
    5. Lin YL,
    6. Song Y, et al.
    LPS enhances the chemosensitivity of oxaliplatin in HT29 cells via GSDMD-mediated pyroptosis. Cancer Manag Res. 2020; 12: 10397–409.
    OpenUrlPubMed
  26. 26.↵
    1. Madore AM,
    2. Pain L,
    3. Boucher-Lafleur AM,
    4. Morin A,
    5. Meloche J,
    6. Simon MM, et al.
    Asthma-associated polymorphisms in 17q12-21 locus modulate methylation and gene expression of GSDMA in naïve CD4+ T cells. J Genet Genomics. 2020; 47: 171–4.
    OpenUrlPubMed
  27. 27.↵
    1. Moreno-Moral A,
    2. Bagnati M,
    3. Koturan S,
    4. Ko JH,
    5. Fonseca C,
    6. Harmston N, et al.
    Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk. Ann Rheum Dis. 2018; 77: 596–601.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Deng W,
    2. Bai Y,
    3. Deng F,
    4. Pan Y,
    5. Mei S,
    6. Zheng Z, et al.
    Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis. Nature. 2022; 602: 496–502.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. LaRock DL,
    2. Johnson AF,
    3. Wilde S,
    4. Sands JS,
    5. Monteiro MP,
    6. LaRock CN.
    Group A Streptococcus induces GSDMA-dependent pyroptosis in keratinocytes. Nature. 2022; 605: 527–31.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Orita H,
    2. Tanaka S,
    3. Watanabe S,
    4. Matsuzawa H,
    5. Mizuguchi K,
    6. Ito T, et al.
    Abstract 3424: The efficacy of Gasdermin gene family for tumor marker in colorectal cancer. Cancer Res. 2015; 75: 3424.
    OpenUrl
  31. 31.↵
    1. Yin H,
    2. Zhao Z,
    3. Yan Y,
    4. Yuan Y,
    5. Qu W,
    6. Wang H, et al.
    Seneca Valley virus circumvents Gasdermin A-mediated inflammation by targeting the pore-formation domain for cleavage. mBio. 2024; 15: e0168024.
  32. 32.↵
    1. Zhang H,
    2. Du Y,
    3. Qi L,
    4. Xiao S,
    5. Braun FK,
    6. Kogiso M, et al.
    Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models. J Transl Med. 2023; 21: 444.
    OpenUrlPubMed
  33. 33.↵
    1. Li L,
    2. Li Y,
    3. Bai Y.
    Role of GSDMB in pyroptosis and cancer. Cancer Manag Res. 2020; 12: 3033–43.
    OpenUrlPubMed
  34. 34.↵
    1. Kong Q,
    2. Xia S,
    3. Pan X,
    4. Ye K,
    5. Li Z,
    6. Li H, et al.
    Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis. Sci Immunol. 2023; 8: eadg3196.
  35. 35.↵
    1. Zhong X,
    2. Zeng H,
    3. Zhou Z,
    4. Su Y,
    5. Cheng H,
    6. Hou Y, et al.
    Structural mechanisms for regulation of GSDMB pore-forming activity. Nature. 2023; 616: 598–605.
    OpenUrlPubMed
  36. 36.↵
    1. Oltra SS,
    2. Colomo S,
    3. Sin L,
    4. Pérez-López M,
    5. Lázaro S,
    6. Molina-Crespo A, et al.
    Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells. Cell Death Differ. 2023; 30: 1366–81.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Cui Y,
    2. Zhou Z,
    3. Chai Y,
    4. Zhang Y.
    Upregulated GSDMB in clear cell renal cell carcinoma is associated with immune infiltrates and poor prognosis. J Immunol Res. 2021; 2021: 7753553.
  38. 38.↵
    1. Gámez-Chiachio M,
    2. Molina-Crespo Á,
    3. Ramos-Nebot C,
    4. Martinez-Val J,
    5. Martinez L,
    6. Gassner K, et al.
    Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation. J Exp Clin Cancer Res. 2022; 41: 285.
    OpenUrlPubMed
  39. 39.↵
    1. Kusumaningrum N,
    2. Lee DH,
    3. Yoon HS,
    4. Kim YK,
    5. Park CH,
    6. Chung JH.
    Gasdermin C is induced by ultraviolet light and contributes to MMP-1 expression via activation of ERK and JNK pathways. J Dermatol Sci. 2018; 90: 180–9.
    OpenUrlPubMed
  40. 40.↵
    1. Kusumaningrum N,
    2. Lee DH,
    3. Yoon HS,
    4. Park CH,
    5. Chung JH.
    Ultraviolet light-induced gasdermin C expression is mediated via TRPV1/calcium/calcineurin/NFATc1 signaling. Int J Mol Med. 2018; 42: 2859–66.
    OpenUrlPubMed
  41. 41.↵
    1. Wei J,
    2. Xu Z,
    3. Chen X,
    4. Wang X,
    5. Zeng S,
    6. Qian L, et al.
    Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma. Mol Med Rep. 2020; 21: 360–70.
    OpenUrlPubMed
  42. 42.↵
    1. Sun K,
    2. Chen RX,
    3. Li JZ,
    4. Luo ZX.
    LINC00511/hsa-miR-573 axis-mediated high expression of Gasdermin C associates with dismal prognosis and tumor immune infiltration of breast cancer. Sci Rep. 2022; 12: 14788.
  43. 43.↵
    1. Hou J,
    2. Zhao R,
    3. Xia W,
    4. Chang CW,
    5. You Y,
    6. Hsu JM, et al.
    PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020; 22: 1264–75.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Zhang JY,
    2. Zhou B,
    3. Sun RY,
    4. Ai YL,
    5. Cheng K,
    6. Li FN, et al.
    The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8. Cell Res. 2021; 31: 980–97.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Sawant DA,
    2. Tharakan B,
    3. Wilson RL,
    4. Stagg HW,
    5. Hunter FA,
    6. Childs EW.
    Regulation of tumor necrosis factor-α-induced microvascular endothelial cell hyperpermeability by recombinant B-cell lymphoma-extra large. J Surg Res. 2013; 184: 628–37.
    OpenUrlPubMed
  46. 46.↵
    1. Saeki N,
    2. Usui T,
    3. Aoyagi K,
    4. Kim DH,
    5. Sato M,
    6. Mabuchi T, et al.
    Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes Chromosomes Cancer. 2009; 48: 261–71.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    1. Kayagaki N,
    2. Stowe IB,
    3. Lee BL,
    4. O’Rourke K,
    5. Anderson K,
    6. Warming S, et al.
    Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015; 526: 666–71.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Ding X,
    2. Kambara H,
    3. Guo R,
    4. Kanneganti A,
    5. Acosta-Zaldívar M,
    6. Li J, et al.
    Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages. Nat Commun. 2021; 12: 6699.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Peng X,
    2. Na R,
    3. Zhou W,
    4. Meng X,
    5. Yang Y,
    6. Amini S, et al.
    Nuclear translocation of Gasdermin D sensitizes colorectal cancer to chemotherapy in a pyroptosis-independent manner. Oncogene. 2022; 41: 5092–106.
    OpenUrlPubMed
  50. 50.↵
    1. Kim MS,
    2. Chang X,
    3. Yamashita K,
    4. Nagpal JK,
    5. Baek JH,
    6. Wu G, et al.
    Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene. 2008; 27: 3624–34.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    1. Yu J,
    2. Li S,
    3. Qi J,
    4. Chen Z,
    5. Wu Y,
    6. Guo J, et al.
    Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells. Cell Death Dis. 2019; 10: 193.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Jia C,
    2. Zhang Z,
    3. Tang J,
    4. Cai MC,
    5. Zang J,
    6. Shi K, et al.
    Epithelial-mesenchymal transition induces GSDME transcriptional activation for inflammatory pyroptosis. Front Cell Dev Biol. 2021; 9: 781365.
  53. 53.↵
    1. Tan G,
    2. Lin C,
    3. Huang C,
    4. Chen B,
    5. Chen J,
    6. Shi Y, et al.
    Radiosensitivity of colorectal cancer and radiation-induced gut damages are regulated by gasdermin E. Cancer Lett. 2022; 529: 1–10.
    OpenUrlCrossRefPubMed
  54. 54.↵
    1. Chen Y,
    2. Lian N,
    3. Chen S,
    4. Xiao T,
    5. Ke Y,
    6. Zhang Y, et al.
    GSDME deficiency leads to the aggravation of UVB-induced skin inflammation through enhancing recruitment and activation of neutrophils. Cell Death Dis. 2022; 13: 841.
    OpenUrlPubMed
  55. 55.↵
    1. Li D,
    2. Wu M.
    Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021; 6: 291.
    OpenUrlPubMed
  56. 56.↵
    1. Sharma BR,
    2. Kanneganti TD.
    NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021; 22: 550–9.
    OpenUrlCrossRefPubMed
  57. 57.
    1. He Y,
    2. Hara H,
    3. Núñez G.
    Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016; 41: 1012–21.
    OpenUrlCrossRefPubMed
  58. 58.↵
    1. Karki R,
    2. Sundaram B,
    3. Sharma BR,
    4. Lee S,
    5. Malireddi RKS,
    6. Nguyen LN, et al.
    ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep. 2021; 37: 109858.
  59. 59.↵
    1. Kuriakose T,
    2. Man SM,
    3. Malireddi RK,
    4. Karki R,
    5. Kesavardhana S,
    6. Place DE, et al.
    ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol. 2016; 1: aag2045.
  60. 60.↵
    1. Banoth B,
    2. Tuladhar S,
    3. Karki R,
    4. Sharma BR,
    5. Briard B,
    6. Kesavardhana S, et al.
    ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis). J Biol Chem. 2020; 295: 18276–83.
    OpenUrlAbstract/FREE Full Text
  61. 61.↵
    1. Bauernfried S,
    2. Hornung V.
    Human NLRP1: from the shadows to center stage. J Exp Med. 2022; 219: e20211405.
  62. 62.↵
    1. Zheng M,
    2. Kanneganti TD.
    The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020; 297: 26–38.
    OpenUrlCrossRefPubMed
  63. 63.↵
    1. Li Y,
    2. Fu TM,
    3. Lu A,
    4. Witt K,
    5. Ruan J,
    6. Shen C, et al.
    Cryo-EM structures of ASC and NLRC4 CARD filaments reveal a unified mechanism of nucleation and activation of caspase-1. Proc Natl Acad Sci U S A. 2018; 115: 10845–52.
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    1. Lugrin J,
    2. Martinon F.
    The AIM2 inflammasome: sensor of pathogens and cellular perturbations. Immunol Rev. 2018; 281: 99–114.
    OpenUrlCrossRefPubMed
  65. 65.↵
    1. Bolívar BE,
    2. Brown-Suedel AN,
    3. Rohrman BA,
    4. Charendoff CI,
    5. Yazdani V,
    6. Belcher JD, et al.
    Noncanonical roles of caspase-4 and caspase-5 in heme-driven IL-1β release and cell death. J Immunol. 2021; 206: 1878–89.
    OpenUrlAbstract/FREE Full Text
  66. 66.↵
    1. Li Z,
    2. Cai Q,
    3. Li B,
    4. Meng W.
    Caspase-11/4 is involved in bacteria-mediated periodontitis by promoting the release of interleukin-1 β and tumor necrosis factor-α. Arch Oral Biol. 2022; 142: 105517.
  67. 67.↵
    1. Kiselevsky DB.
    Granzymes and mitochondria. Biochemistry. 2020; 85: 131–9.
    OpenUrlPubMed
  68. 68.↵
    1. Liu Y,
    2. Fang Y,
    3. Chen X,
    4. Wang Z,
    5. Liang X,
    6. Zhang T, et al.
    Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol. 2020; 5: eaax7969.
  69. 69.↵
    1. Liu Z,
    2. Li Y,
    3. Zhu Y,
    4. Li N,
    5. Li W,
    6. Shang C, et al.
    Apoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway. Int J Biol Sci. 2022; 18: 717–30.
    OpenUrlCrossRefPubMed
  70. 70.
    1. Vernon M,
    2. Wilski NA,
    3. Kotas D,
    4. Cai W,
    5. Pomante D,
    6. Tiago M, et al.
    Raptinal induces gasdermin E-dependent pyroptosis in naïve and therapy-resistant melanoma. Mol Cancer Res. 2022; 20: 1811–21.
    OpenUrlPubMed
  71. 71.↵
    1. Hu Y,
    2. Wen Q,
    3. Cai Y,
    4. Liu Y,
    5. Ma W,
    6. Li Q, et al.
    Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway. Phytomedicine. 2023; 108: 154528.
  72. 72.↵
    1. Malireddi RKS,
    2. Kesavardhana S,
    3. Kanneganti TD.
    ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019; 9: 406.
    OpenUrlPubMed
  73. 73.↵
    1. Malireddi RKS,
    2. Tweedell RE,
    3. Kanneganti TD.
    PANoptosis components, regulation, and implications. Aging (Albany NY). 2020; 12: 11163–4.
    OpenUrlPubMed
  74. 74.↵
    1. Upmanyu K,
    2. Upadhyay S.
    Wiring and rewiring PANoptosis: molecular vulnerabilities for targeting inflammatory cell death in human disease. Cytokine Growth Factor Rev. 2025; 86: 1–16.
    OpenUrlPubMed
  75. 75.↵
    1. Wang L,
    2. Yan H,
    3. Chen X,
    4. Lee J,
    5. Sun J,
    6. Liu G, et al.
    Caspase-8 is involved in pyroptosis, necroptosis and the maturation and release of IL-1β in Aspergillus fumigatus keratitis. Int Immunopharmacol. 2022; 113: 109275.
  76. 76.↵
    1. Orning P,
    2. Weng D,
    3. Starheim K,
    4. Ratner D,
    5. Best Z,
    6. Lee B, et al.
    Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science. 2018; 362: 1064–9.
    OpenUrlAbstract/FREE Full Text
  77. 77.↵
    1. Wang Y,
    2. Gao W,
    3. Shi X,
    4. Ding J,
    5. Liu W,
    6. He H, et al.
    Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017; 547: 99–103.
    OpenUrlCrossRefPubMed
  78. 78.↵
    1. Gao J,
    2. Qiu X,
    3. Xi G,
    4. Liu H,
    5. Zhang F,
    6. Lv T, et al.
    Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non-small cell lung cancer. Oncol Rep. 2018; 40: 1971–84.
    OpenUrlCrossRefPubMed
  79. 79.↵
    1. Galluzzi L,
    2. Kepp O,
    3. Zitvogel L,
    4. Tang D,
    5. Kroemer G.
    Cancer cell death: cell-autonomous and immunogenic dimensions. Cancer Cell. 2026; 44: 281–305.
    OpenUrlPubMed
  80. 80.↵
    1. Chen H,
    2. Li Y,
    3. Wu J,
    4. Li G,
    5. Tao X,
    6. Lai K, et al.
    RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis. Cell Death Differ. 2020; 27: 2568–85.
    OpenUrlPubMed
  81. 81.↵
    1. Wang H,
    2. He Z,
    3. Gao Y,
    4. Feng D,
    5. Wei X,
    6. Huang Y, et al.
    Dual-pronged attack: pH-driven membrane-anchored NIR dual-type nano-photosensitizer excites immunogenic pyroptosis and sequester immune checkpoint for enhanced prostate cancer photo-immunotherapy. Adv Sci (Weinh). 2023; 10: e2302422.
  82. 82.↵
    1. Wang H,
    2. Feng X,
    3. He H,
    4. Li L,
    5. Wen Y,
    6. Liu X, et al.
    Crosstalk between autophagy and other forms of programmed cell death. Eur J Pharmacol. 2025; 995: 177414.
  83. 83.↵
    1. Zhang H,
    2. Ni W,
    3. Yu G,
    4. Geng Y,
    5. Lou J,
    6. Qi J, et al.
    3,4-Dimethoxychalcone, a caloric restriction mimetic, enhances TFEB-mediated autophagy and alleviates pyroptosis and necroptosis after spinal cord injury. Theranostics. 2023; 13: 810–32.
    OpenUrlPubMed
  84. 84.↵
    1. Corà D,
    2. Bussolino F,
    3. Doronzo G.
    TFEB signalling-related microRNAs and autophagy. Biomolecules. 2021; 11: 985.
    OpenUrlPubMed
  85. 85.↵
    1. Pei X,
    2. Liu D,
    3. Li J,
    4. Li L,
    5. Ding X,
    6. Zhang W, et al.
    TFEB coordinates autophagy and pyroptosis as hepatotoxicity responses to ZnO nanoparticles. Sci Total Environ. 2022; 865: 161242.
  86. 86.↵
    1. Ju X,
    2. Zhang H,
    3. Wang J,
    4. Sun Z,
    5. Guo L,
    6. Wang Q.
    Shikonin triggers GSDME-mediated pyroptosis in tumours by regulating autophagy via the ROS-MAPK14/p38α axis. Phytomedicine. 2023; 109: 154596.
  87. 87.↵
    1. Liu W,
    2. Gan Y,
    3. Ding Y,
    4. Zhang L,
    5. Jiao X,
    6. Liu L, et al.
    Autophagy promotes GSDME-mediated pyroptosis via intrinsic and extrinsic apoptotic pathways in cobalt chloride-induced hypoxia reoxygenation-acute kidney injury. Ecotoxicol Environ Saf. 2022; 242: 113881.
  88. 88.↵
    1. Ruan J,
    2. Wang S,
    3. Wang J.
    Mechanism and regulation of pyroptosis-mediated in cancer cell death. Chem Biol Interact. 2020; 323: 109052.
  89. 89.↵
    1. Grivennikov SI,
    2. Greten FR,
    3. Karin M.
    Immunity, inflammation, and cancer. Cell. 2010; 140: 883–99.
    OpenUrlCrossRefPubMedWeb of Science
  90. 90.↵
    1. Vakkila J,
    2. Lotze MT.
    Inflammation and necrosis promote tumour growth. Nat Rev Immunol. 2004; 4: 641–8.
    OpenUrlCrossRefPubMedWeb of Science
  91. 91.↵
    1. Uz U,
    2. Eskiizmir G.
    Association between interleukin-6 and head and neck squamous cell carcinoma: a systematic review. Clin Exp Otorhinolaryngol. 2021; 14: 50–60.
    OpenUrlPubMed
  92. 92.↵
    1. Huang CF,
    2. Chen L,
    3. Li YC,
    4. Wu L,
    5. Yu GT,
    6. Zhang WF, et al.
    NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2017; 36: 116.
    OpenUrlPubMed
  93. 93.↵
    1. Lu L,
    2. Wang P,
    3. Zou Y,
    4. Zha Z,
    5. Huang H,
    6. Guan M, et al.
    IL-1β promotes stemness of tumor cells by activating Smad/ID1 signaling pathway. Int J Med Sci. 2020; 17: 1257–68.
    OpenUrlCrossRefPubMed
  94. 94.↵
    1. Liu W,
    2. Zhang F,
    3. Quan B,
    4. Yao F,
    5. Chen R,
    6. Ren Z, et al.
    NLRP3/IL-1β induced myeloid-derived suppressor cells recruitment and PD-L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma. MedComm. 2023; 4: e447.
  95. 95.↵
    1. Meyer C,
    2. Sevko A,
    3. Ramacher M,
    4. Bazhin AV,
    5. Falk CS,
    6. Osen W, et al.
    Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A. 2011; 108: 17111–6.
    OpenUrlAbstract/FREE Full Text
  96. 96.↵
    1. Jiang Y,
    2. Liu H,
    3. Yu H,
    4. Zhou Y,
    5. Zhang J,
    6. Xin W, et al.
    Circular RNA Calm4 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis via the Circ-Calm4/miR-124-3p/PDCD6 axis. Arterioscler Thromb Vasc Biol. 2021; 41: 1675–93.
    OpenUrlCrossRefPubMed
  97. 97.↵
    1. Tsuchiya K.
    Switching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor immunity. Int J Mol Sci. 2021; 22: 426.
    OpenUrlPubMed
  98. 98.↵
    1. Li Q,
    2. Hong Y,
    3. Chen J,
    4. Zhou X,
    5. Tian X,
    6. Yu Y, et al.
    Hypoxia-induced HIF-1α expression promotes neurogenic bladder fibrosis via EMT and pyroptosis. Cells. 2022; 11: 3836.
    OpenUrl
  99. 99.↵
    1. Chen YR,
    2. Yeh HC,
    3. Chiu FY,
    4. Wu HE,
    5. Fang HC,
    6. Li CY.
    The role of HIF-1α in regulating NLRP3 inflammasome activation in bladder cancer. J Clin Oncol. 2020; 38: e17028.
  100. 100.↵
    1. Wang X,
    2. Yin Y,
    3. Qian W,
    4. Peng C,
    5. Shen S,
    6. Wang T, et al.
    Citric acid of ovarian cancer metabolite induces pyroptosis via the caspase-4/TXNIP-NLRP3-GSDMD pathway in ovarian cancer. FASEB J. 2022; 36: e22362.
  101. 101.↵
    1. Nieto MA,
    2. Huang RY,
    3. Jackson RA,
    4. Thiery JP.
    EMT: 2016. Cell. 2016; 166: 21–45.
    OpenUrlCrossRefPubMed
  102. 102.↵
    1. Liang M,
    2. Li JW,
    3. Luo H,
    4. Lulu S,
    5. Calbay O,
    6. Shenoy A, et al.
    Epithelial-mesenchymal transition suppresses AMPK and sensitizes cancer cells to pyroptosis under energy stress. Cells. 2022; 11: 2208.
    OpenUrlCrossRef
  103. 103.↵
    1. Han J,
    2. Cheng C,
    3. Zhang J,
    4. Fang J,
    5. Yao W,
    6. Zhu Y, et al.
    Myricetin activates the Caspase-3/GSDME pathway via ER stress induction of pyroptosis in lung cancer cells. Front Pharmacol. 2022; 13: 959938.
  104. 104.↵
    1. Wang H,
    2. Rong X,
    3. Zhao G,
    4. Zhou Y,
    5. Xiao Y,
    6. Ma D, et al.
    The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metab. 2022; 34: 581–94.e8.
    OpenUrlCrossRefPubMed
  105. 105.↵
    1. Yan H,
    2. Luo B,
    3. Wu X,
    4. Guan F,
    5. Yu X,
    6. Zhao L, et al.
    Cisplatin induces pyroptosis via activation of MEG3/NLRP3/caspase-1/GSDMD pathway in triple-negative breast cancer. Int J Biol Sci. 2021; 17: 2606–21.
    OpenUrlCrossRefPubMed
  106. 106.
    1. Cheng Z,
    2. Li Z,
    3. Gu L,
    4. Li L,
    5. Gao Q,
    6. Zhang X, et al.
    Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis. J Cancer. 2022; 13: 715–27.
    OpenUrlPubMed
  107. 107.↵
    1. Yuan R,
    2. Zhao W,
    3. Wang QQ,
    4. He J,
    5. Han S,
    6. Gao H, et al.
    Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis. Pharmacol Res. 2021; 170: 105748.
  108. 108.↵
    1. Yang Y,
    2. Liu PY,
    3. Bao W,
    4. Chen SJ,
    5. Wu FS,
    6. Zhu PY.
    Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway. BMC Cancer. 2020; 20: 28.
    OpenUrlCrossRefPubMed
  109. 109.↵
    1. Teng JF,
    2. Mei QB,
    3. Zhou XG,
    4. Tang Y,
    5. Xiong R,
    6. Qiu WQ, et al.
    Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer. Cancers (Basel). 2020; 12: 193.
    OpenUrlPubMed
  110. 110.↵
    1. Qiao L,
    2. Wu X,
    3. Zhang J,
    4. Liu L,
    5. Sui X,
    6. Zhang R, et al.
    α-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway. FASEB J. 2019; 33: 12760–7.
    OpenUrlPubMed
  111. 111.↵
    1. Sala R,
    2. Rioja-Blanco E,
    3. Serna N,
    4. Sánchez-García L,
    5. Álamo P,
    6. Alba-Castellón L, et al.
    GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases. Drug Deliv. 2022; 29: 1384–97.
    OpenUrlPubMed
  112. 112.↵
    1. Ding B,
    2. Chen H,
    3. Tan J,
    4. Meng Q,
    5. Zheng P,
    6. Ma P, et al.
    ZIF-8 nanoparticles evoke pyroptosis for high-efficiency cancer immunotherapy. Angew Chem Int Ed Engl. 2023; 62: e202215307.
  113. 113.↵
    1. Xu Q,
    2. Jin X,
    3. Song S,
    4. Zhang H,
    5. Ding H,
    6. Liu C, et al.
    pH-responsive ZIF-8@quercetin nanoparticles induce pyroptosis for targeted gastric cancer therapy. Mater Today Bio. 2026; 37: 102806.
  114. 114.↵
    1. Yan X,
    2. Chen C,
    3. Ren Y,
    4. Su T,
    5. Chen H,
    6. Yu D, et al.
    A dual-pathway pyroptosis inducer based on Au-Cu2−xSe@ZIF-8 enhances tumor immunotherapy by disrupting the zinc ion homeostasis. Acta Biomater. 2024; 188: 329–43.
    OpenUrlPubMed
  115. 115.↵
    1. Tran TV,
    2. Dang HH,
    3. Nguyen H,
    4. Nguyen NTT,
    5. Nguyen DH,
    6. Nguyen TTT.
    Synthesis methods, structure, and recent trends of ZIF-8-based materials in the biomedical field. Nanoscale Adv. 2025; 7: 3941–60.
    OpenUrlPubMed
  116. 116.↵
    1. Xing Y,
    2. Zhang F,
    3. Ji P,
    4. Wei M,
    5. Yin C,
    6. Yang A, et al.
    Efficient delivery of GSDMD-N mRNA by engineered extracellular vesicles induces pyroptosis for enhanced immunotherapy. Small. 2023; 19: e2204031.
  117. 117.↵
    1. Zhang MJ,
    2. Gao W,
    3. Liu S,
    4. Siu SP,
    5. Yin M,
    6. Ng JC, et al.
    CD38 triggers inflammasome-mediated pyroptotic cell death in head and neck squamous cell carcinoma. Am J Cancer Res. 2020; 10: 2895–908.
    OpenUrlPubMed
  118. 118.↵
    1. Zhang H,
    2. Du Y,
    3. Guo Y,
    4. Wang Z,
    5. Li H,
    6. Lv Z, et al.
    TLR4-NLRP3-GSDMD-mediated pyroptosis plays an important role in aggravated liver injury of CD38−/− sepsis mice. J Immunol Res. 2021; 2021: 6687555.
  119. 119.↵
    1. Yan Z,
    2. Da Q,
    3. Li Z,
    4. Lin Q,
    5. Yi J,
    6. Su Y, et al.
    Inhibition of NEK7 suppressed hepatocellular carcinoma progression by mediating cancer cell pyroptosis. Front Oncol. 2022; 12: 812655.
  120. 120.↵
    1. Huo J,
    2. Shen Y,
    3. Zhang Y,
    4. Shen L.
    BI 2536 induces gasdermin E-dependent pyroptosis in ovarian cancer. Front Oncol. 2022; 12: 963928.
  121. 121.
    1. Sun X,
    2. Zhong X,
    3. Ma W,
    4. Feng W,
    5. Huang Q,
    6. Ma M, et al.
    Germacrone induces caspase-3/GSDME activation and enhances ROS production, causing HepG2 pyroptosis. Exp Ther Med. 2022; 24: 456.
    OpenUrlPubMed
  122. 122.
    1. Liang J,
    2. Zhou J,
    3. Xu Y,
    4. Huang X,
    5. Wang X,
    6. Huang W, et al.
    Osthole inhibits ovarian carcinoma cells through LC3-mediated autophagy and GSDME-dependent pyroptosis except for apoptosis. Eur J Pharmacol. 2020; 874: 172990.
  123. 123.
    1. Chen J,
    2. Ge L,
    3. Shi X,
    4. Liu J,
    5. Ruan H,
    6. Heng D, et al.
    Lobaplatin induces pyroptosis in cervical cancer cells via the Caspase-3/GSDME pathway. Anticancer Agents Med Chem. 2022; 22: 2091–7.
    OpenUrlPubMed
  124. 124.↵
    1. Rioja-Blanco E,
    2. Arroyo-Solera I,
    3. Álamo P,
    4. Casanova I,
    5. Gallardo A,
    6. Unzueta U, et al.
    CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2022; 41: 49.
    OpenUrlPubMed
  125. 125.↵
    1. Zheng Z,
    2. Bian Y,
    3. Zhang Y,
    4. Ren G,
    5. Li G.
    Metformin activates AMPK/SIRT1/NF-κB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis. Cell Cycle. 2020; 19: 1089–104.
    OpenUrlCrossRefPubMed
  126. 126.↵
    1. Yan L,
    2. Liu Y,
    3. Ma XF,
    4. Hou D,
    5. Zhang YH,
    6. Sun Y, et al.
    Triclabendazole induces pyroptosis by activating caspase-3 to cleave GSDME in breast cancer cells. Front Pharmacol. 2021; 12: 670081.
  127. 127.↵
    1. Guo J,
    2. Zheng J,
    3. Mu M,
    4. Chen Z,
    5. Xu Z,
    6. Zhao C, et al.
    GW4064 enhances the chemosensitivity of colorectal cancer to oxaliplatin by inducing pyroptosis. Biochem Biophys Res Commun. 2021; 548: 60–6.
    OpenUrlPubMed
  128. 128.↵
    1. Li T,
    2. Shi L,
    3. Liu W,
    4. Hu X,
    5. Hui Y,
    6. Di M, et al.
    Aloe-emodin induces mitochondrial dysfunction and pyroptosis by activation of the caspase-9/3/gasdermin E axis in HeLa cells. Front Pharmacol. 2022; 13: 854526.
  129. 129.↵
    1. Shangguan F,
    2. Zhou H,
    3. Ma N,
    4. Wu S,
    5. Huang H,
    6. Jin G, et al.
    A novel mechanism of cannabidiol in suppressing hepatocellular carcinoma by inducing GSDME dependent pyroptosis. Front Cell Dev Biol. 2021; 9: 697832.
  130. 130.↵
    1. Zhang Y,
    2. Yang J,
    3. Wen Z,
    4. Chen X,
    5. Yu J,
    6. Yuan D, et al.
    A novel 3′,5′-diprenylated chalcone induces concurrent apoptosis and GSDME-dependent pyroptosis through activating PKCδ/JNK signal in prostate cancer. Aging (Albany NY). 2020; 12: 9103–24.
    OpenUrlPubMed
  131. 131.↵
    1. Tan JQ,
    2. Li Z,
    3. Chen G,
    4. Wu M,
    5. Feng JL,
    6. Kong SY, et al.
    The natural compound from Garcinia bracteata mainly induces GSDME-mediated pyroptosis in esophageal cancer cells. Phytomedicine. 2022; 102: 154142.
  132. 132.↵
    1. Kobayashi T,
    2. Mitsuhashi A,
    3. Hongying P,
    4. Shioya M,
    5. Kojima K,
    6. Nishikimi K, et al.
    Bexarotene-induced cell death in ovarian cancer cells through Caspase-4-gasdermin E mediated pyroptosis. Sci Rep. 2022; 12: 11123.
  133. 133.↵
    1. Jiang H,
    2. Niu C,
    3. Guo Y,
    4. Liu Z,
    5. Jiang Y.
    Wedelolactone induces apoptosis and pyroptosis in retinoblastoma through promoting ROS generation. Int Immunopharmacol. 2022; 111: 108855.
  134. 134.↵
    1. Yu F,
    2. Tan W,
    3. Chen Z,
    4. Shen X,
    5. Mo X,
    6. Mo X, et al.
    Nitidine chloride induces caspase 3/GSDME-dependent pyroptosis by inhibiting PI3K/Akt pathway in lung cancer. Chin Med. 2022; 17: 115.
    OpenUrlPubMed
  135. 135.
    1. Zhang X,
    2. Zhang P,
    3. An L,
    4. Sun N,
    5. Peng L,
    6. Tang W, et al.
    Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis. Acta Pharm Sin B. 2020; 10: 1397–413.
    OpenUrlPubMed
  136. 136.↵
    1. Yang Q,
    2. Ma X,
    3. Xiao Y,
    4. Zhang T,
    5. Yang L,
    6. Yang S, et al.
    Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity. Acta Pharm Sin B. 2022; 12: 3139–55.
    OpenUrlPubMed
  137. 137.↵
    1. Lv J,
    2. Liu Y,
    3. Mo S,
    4. Zhou Y,
    5. Chen F,
    6. Cheng F, et al.
    Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1–mucin pathway. Nat Cell Biol. 2022; 24: 364–72.
    OpenUrlPubMed
  138. 138.↵
    1. Wang J,
    2. Zhan L,
    3. Cai Z,
    4. Liu X,
    5. Wang J,
    6. Zhong H, et al.
    Arsenic trioxide induces gasdermin E mediated pyroptosis in astroglioma cells. Transl Cancer Res. 2020; 9: 1926–30.
    OpenUrlPubMed
  139. 139.
    1. Ding Q,
    2. Zhang W,
    3. Cheng C,
    4. Mo F,
    5. Chen L,
    6. Peng G, et al.
    Dioscin inhibits the growth of human osteosarcoma by inducing G2/M-phase arrest, apoptosis, and GSDME-dependent cell death in vitro and in vivo. J Cell Physiol. 2020; 235: 2911–24.
    OpenUrlPubMed
  140. 140.
    1. Lin J,
    2. Sun S,
    3. Zhao K,
    4. Gao F,
    5. Wang R,
    6. Li Q, et al.
    Oncolytic parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity. Nat Commun. 2023; 14: 224.
    OpenUrlPubMed
  141. 141.↵
    1. Ma L,
    2. Bian M,
    3. Gao H,
    4. Zhou Z,
    5. Yi W.
    A novel 3-acyl isoquinolin-1(2H)-one induces G2 phase arrest, apoptosis and GSDME-dependent pyroptosis in breast cancer. PLoS One. 2022; 17: e0268060.
  142. 142.↵
    1. Di M,
    2. Miao J,
    3. Pan Q,
    4. Wu Z,
    5. Chen B,
    6. Wang M, et al.
    OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis. J Exp Clin Cancer Res. 2022; 41: 328.
    OpenUrlPubMed
  143. 143.↵
    1. Deng BB,
    2. Jiao BP,
    3. Liu YJ,
    4. Li YR,
    5. Wang GJ.
    BIX-01294 enhanced chemotherapy effect in gastric cancer by inducing GSDME-mediated pyroptosis. Cell Biol Int. 2020; 44: 1890–9.
    OpenUrlPubMed
  144. 144.↵
    1. Wang Y,
    2. Peng J,
    3. Mi X,
    4. Yang M.
    p53–GSDME elevation: a path for CDK7 inhibition to suppress breast cancer cell survival. Front Mol Biosci. 2021; 8: 697457.
  145. 145.↵
    1. Xia J,
    2. Chu C,
    3. Li W,
    4. Chen H,
    5. Xie W,
    6. Cheng R, et al.
    Mitochondrial protein UCP1 inhibits the malignant behaviors of triple-negative breast cancer through activation of mitophagy and pyroptosis. Int J Biol Sci. 2022; 18: 2949–61.
    OpenUrlPubMed
  146. 146.↵
    1. Li RY,
    2. Zheng ZY,
    3. Li ZM,
    4. Heng JH,
    5. Zheng YQ,
    6. Deng DX, et al.
    Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer. Chem Biol Interact. 2022; 361: 109967.
  147. 147.↵
    1. Zhou B,
    2. Zhang JY,
    3. Liu XS,
    4. Chen HZ,
    5. Ai YL,
    6. Cheng K, et al.
    Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis. Cell Res. 2018; 28: 1171–85.
    OpenUrlCrossRefPubMed
  148. 148.↵
    1. Qin T,
    2. Wang C,
    3. Chen X,
    4. Duan C,
    5. Zhang X,
    6. Zhang J, et al.
    Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma. Toxicol Appl Pharmacol. 2015; 286: 112–23.
    OpenUrlPubMed
  149. 149.↵
    1. Tan Y,
    2. Sun R,
    3. Liu L,
    4. Yang D,
    5. Xiang Q,
    6. Li L, et al.
    Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer. Theranostics. 2021; 11: 5214–31.
    OpenUrlPubMed
  150. 150.↵
    1. Su L,
    2. Chen Y,
    3. Huang C,
    4. Wu S,
    5. Wang X,
    6. Zhao X, et al.
    Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. Sci Transl Med. 2023; 15: eabl7895.
  151. 151.↵
    1. An H,
    2. Heo JS,
    3. Kim P,
    4. Lian Z,
    5. Lee S,
    6. Park J, et al.
    Tetraarsenic hexoxide enhances generation of mitochondrial ROS to promote pyroptosis by inducing the activation of caspase-3/GSDME in triple-negative breast cancer cells. Cell Death Dis. 2021; 12: 159.
    OpenUrlCrossRefPubMed
  152. 152.↵
    1. Zheng ZY,
    2. Yang PL,
    3. Li RY,
    4. Liu LX,
    5. Xu XE,
    6. Liao LD, et al.
    STAT3β disrupted mitochondrial electron transport chain enhances chemosensitivity by inducing pyroptosis in esophageal squamous cell carcinoma. Cancer Lett. 2021; 522: 171–83.
    OpenUrlPubMed
  153. 153.↵
    1. Li L,
    2. Song D,
    3. Qi L,
    4. Jiang M,
    5. Wu Y,
    6. Gan J, et al.
    Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis. Cancer Lett. 2021; 520: 143–59.
    OpenUrlPubMed
  154. 154.↵
    1. Jiang M,
    2. Wu Y,
    3. Qi L,
    4. Li L,
    5. Song D,
    6. Gan J, et al.
    Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma. Chem Biol Interact. 2021; 350: 109704.
  155. 155.↵
    1. Wang J,
    2. Huangfu M,
    3. Li X,
    4. Han M,
    5. Liu G,
    6. Yu D, et al.
    Osthole induces apoptosis and caspase-3/GSDME-dependent pyroptosis via NQO1-mediated ROS generation in HeLa cells. Oxid Med Cell Longev. 2022; 2022: 8585598.
  156. 156.↵
    1. Le X,
    2. Mu J,
    3. Peng W,
    4. Tang J,
    5. Xiang Q,
    6. Tian S, et al.
    DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis. Theranostics. 2020; 10: 9495–511.
    OpenUrlCrossRefPubMed
  157. 157.↵
    1. Ling Y,
    2. Wang Y,
    3. Cao C,
    4. Feng L,
    5. Zhang B,
    6. Li S.
    Molecular subtypes identified by pyroptosis-related genes are associated with tumor microenvironment cell infiltration in colon cancer. Aging (Albany NY). 2022; 14: 9020–36.
    OpenUrlPubMed
  158. 158.↵
    1. Wu T,
    2. Li S,
    3. Yu C,
    4. Wu Y,
    5. Long H.
    A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer. Sci Rep. 2022; 12: 21467.
  159. 159.↵
    1. Wang YY,
    2. Shi LY,
    3. Xu MH,
    4. Jing Y,
    5. Sun CC,
    6. Yang JH, et al.
    A pan-cancer analysis of the expression of gasdermin genes in tumors and their relationship with the immune microenvironment. Transl Cancer Res. 2021; 10: 4125–47.
    OpenUrlPubMed
  160. 160.↵
    1. Liu Q,
    2. Fang L,
    3. Gao C,
    4. Liu C,
    5. Yu H,
    6. Wu J, et al.
    Subtype classification, immune infiltration, and prognosis analysis of lung adenocarcinoma based on pyroptosis-related genes. Biomed Res Int. 2022; 2022: 1371315.
  161. 161.↵
    1. Chen W,
    2. Wen MY,
    3. Yang KB,
    4. Zheng LT,
    5. Li X.
    A pyroptosis expression pattern score predicts prognosis and immune microenvironment of lung squamous cell carcinoma. Front Genet. 2022; 13: 996444.
  162. 162.↵
    1. Xiong S,
    2. Jin L,
    3. Zeng C,
    4. Ma H,
    5. Xie L,
    6. Liu S.
    An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer via affecting immune cell infiltration landscape. Pathol Oncol Res. 2022; 28: 1610712.
  163. 163.↵
    1. Li R,
    2. Zhang S,
    3. Liu G.
    Identification and validation of a pyroptosis-related prognostic model for colorectal cancer. Funct Integr Genomics. 2022; 23: 21.
    OpenUrlPubMed
  164. 164.↵
    1. Liu S,
    2. Zeng C,
    3. Lv H,
    4. Zhang Y,
    5. Xiong H,
    6. Tang H.
    A novel defined pyroptosis-related gene signature for predicting the prognosis of endometrial cancer. Dis Markers. 2022; 2022: 7570494.
  165. 165.↵
    1. Luo CG,
    2. Gui CP,
    3. Huang GW,
    4. Chen JL,
    5. Li JY,
    6. Li PJ, et al.
    Identification of ZDHHC1 as a pyroptosis inducer and potential target in the establishment of pyroptosis-related signature in localized prostate cancer. Oxid Med Cell Longev. 2022; 2022: 5925817.
  166. 166.↵
    1. Du X,
    2. Zhao X,
    3. Tang Y,
    4. Tang W.
    Construction of pyroptosis-related prognostic and immune infiltration signature in bladder cancer. Dis Markers. 2022; 2022: 6429993.
  167. 167.↵
    1. Zhou B,
    2. Sha S,
    3. Tao J,
    4. Li J,
    5. Shen C,
    6. Zhu J, et al.
    The expression pattern of pyroptosis-related genes predicts the prognosis and drug response of melanoma. Sci Rep. 2022; 12: 21566.
  168. 168.↵
    1. Xue S,
    2. Shen K,
    3. Wang K,
    4. Ge W,
    5. Mao T,
    6. Li S, et al.
    Prediction of survival and tumor microenvironment infiltration based on pyroptosis-related lncRNAs in pancreatic cancer. Dis Markers. 2022; 2022: 5634887.
  169. 169.↵
    1. Liu Y,
    2. Tang T,
    3. Yang X,
    4. Qin P,
    5. Wang P,
    6. Zhang H, et al.
    Tumor-derived exosomal long noncoding RNA LINC01133, regulated by Periostin, contributes to pancreatic ductal adenocarcinoma epithelial-mesenchymal transition through the Wnt/β-catenin pathway by silencing AXIN2. Oncogene. 2021; 40: 3164–79.
    OpenUrlPubMed
  170. 170.↵
    1. Wang P,
    2. Wang Z,
    3. Zhu L,
    4. Sun Y,
    5. Castellano L,
    6. Stebbing J, et al.
    A pyroptosis-related lncRNA signature in bladder cancer. Cancer Med. 2023; 12: 6348–64.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 23 (10)
Cancer Biology & Medicine
Vol. 23, Issue 10
15 Oct 2026
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pyroptosis in cancer: a dual regulator of tumor cell fate and immune activation
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Pyroptosis in cancer: a dual regulator of tumor cell fate and immune activation
Yuewen Zhang, Mengshi Luo, Zhiqi Liao, Qiuyang Xu, Ding Ma, Qinglei Gao, Tao Zhu, Yong Fang
Cancer Biology & Medicine Oct 2026, 23 (10) 1380-1401; DOI: 10.20892/j.issn.2095-3941.2025.0826

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pyroptosis in cancer: a dual regulator of tumor cell fate and immune activation
Yuewen Zhang, Mengshi Luo, Zhiqi Liao, Qiuyang Xu, Ding Ma, Qinglei Gao, Tao Zhu, Yong Fang
Cancer Biology & Medicine Oct 2026, 23 (10) 1380-1401; DOI: 10.20892/j.issn.2095-3941.2025.0826
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Pyroptosis
    • Pyroptosis in tumors
    • Targeting pyroptosis as cancer therapy
    • Clinical utility of pyroptosis in cancers
    • Conclusions
    • Conflict of interest statement
    • Author contributions
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Treatment implications of T cell DNA damage in anti-tumor immunity
  • Non-coding RNA delivery via lipid nanoparticles: a novel strategy for cancer immunotherapy
Show more Review

Similar Articles

Keywords

  • Pyroptosis
  • gasdermin
  • tumor immunity
  • anticancer therapy
  • prognosis

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire